Serpil Oğuztüzün

ORCID: 0000-0002-5892-3735 · 3 papers in corpus
lab-animal 2020
The Effects of Leukocyte- and Platelet-Rich Plasma (L-Prp) and Pure Platelet-Rich Plasma (P-Prp) in a Rat Endometriosis Model
·doi:10.4103/tjog.tjog_110_19

Objective: We aimed to investigate the effect of platelet-rich plasma (PRP) derivatives, which can be produced from the patient's blood and have minimal side effects, on endometriosis.\nMethods: To our knowledge, this is the first study in …

lab-animal 2019
The Effects of Leukocyte- and Platelet-Rich Plasma (L-Prp) and Pure Platelet-Rich Plasma (P-Prp) an a Rat Endometriosis Model
·doi:10.1101/802421

Abstract Our aim was to investigate the effect of platelet-rich plasma (PRP) derivatives, which can be produced from the patient’s own blood and have minimal side effects, on endometriosis. To the best of our knowledge, this is the first st…

lab-animal 2014
Is montelukast effective in regression of endometrial implants in an experimentally induced endometriosis model in rats?
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.10.026

OBJECTIVE: Montelukast, a selective antagonist of Type 1 cysteinyl leukotriene receptors (CysLT1Rs), antagonizes the proinflammatory and proasthmatic activities of CysLT1Rs. We investigated the effect of montelukast on a surgically induced …